Capital expenditure increased 57.1%
Capital expenditure changed +57.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed +57.1% from the comparable as-filed period.
Working capital changed +21.5% from the comparable as-filed period.
Free-cash-flow margin changed -438 basis points from the comparable as-filed period.
Stock-based compensation changed +32.4% from the comparable as-filed period.
Operating cash flow / net income changed -67.6% from the comparable as-filed period.
Operating cash-flow margin changed -280 basis points from the comparable as-filed period.
Capex / revenue changed +159 basis points from the comparable as-filed period.
Working capital / assets changed +266 basis points from the comparable as-filed period.
Revenue changed -2.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed +9.2% from the comparable as-filed period.
Total assets changed +5.8% from the comparable as-filed period.
Cash & equivalents changed -4.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed +32 basis points from the comparable as-filed period.
Current ratio changed +8.4% from the comparable as-filed period.
Current liabilities changed +0.8% from the comparable as-filed period.
Noncurrent long-term debt changed +0.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.